BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced complex formulation features mannose functionalized and irinotecan hydrochloride loaded cationic liposomes. The structural framework encapsulates the hydrophilic camptothecin derivative irinotecan hydrochloride within its central aqueous core, utilizing a lipid bilayer matrix formulated with cationic lipids to establish a robust positive surface potential, whose exterior boundary is surface-modified with specific D-mannose carbohydrate residues linked via lipid anchors. This complex configuration coordinates a dense target-mimetic carbohydrate interface and high electrostatic stability with an optimized camptothecin matrix, completely preventing physical vesicle aggregation while shielding the volatile lactone ring core from rapid chemical hydrolysis in open laboratory testing media.
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.